Ticker Details
Jazz Pharmaceuticals plc Jazz Pharmaceuticals PLC is a biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing differentiated products that address unmet medical needs.
IPO Date:	June 1, 2007
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$16.51B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.63 | 2.15%
Avg Daily Range (30 D):	$4.34 | 1.74%
Avg Daily Range (90 D):	$4.28 | 1.83%

Institutional Daily Volume
Avg Daily Volume:	.6M
Avg Daily Volume (30 D):	.55M
Avg Daily Volume (90 D):	.67M

Trade Size
Avg Trade Size (Sh.):	80
Avg Trade Size (Sh.) (30 D):	38
Avg Trade Size (Sh.) (90 D):	41

Institutional Trades
Total Institutional Trades:	11,040
Avg Institutional Trade:	$5.17M
Avg Institutional Trade (30 D):	$16.56M
Avg Institutional Trade (90 D):	$13.25M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$8.97M
Avg Closing Trade (30 D):	$29.32M
Avg Closing Trade (90 D):	$31.66M
Avg Closing Volume:	65.21K

News

May 13, 2026 @ 10:00 AM Zymeworks Announces Participation in Upcoming Inve... Source: Na

Apr 20, 2026 @ 5:00 PM Pheochromocytoma and Paraganglioma Market to Exhib... Source: Delveinsight

Feb 16, 2026 @ 1:00 PM Artios Strengthens Leadership Team to Accelerate L... Source: Not Specified

Feb 12, 2026 @ 11:00 AM Zymeworks To Report Fourth Quarter and Full Year 2... Source: Na

Jan 27, 2026 @ 5:02 PM Harmony Biosciences' Sales and Profits Have Soared... Source: Dan Caplinger

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS		$3.05	$4.73
Diluted EPS		$2.78	$4.43
Revenue		$1.21B	$1.07B
Gross Profit
Net Income / Loss		$192.8M	$293.1M
Operating Income / Loss		$248.2M	$336.6M
Cost of Revenue
Net Cash Flow		$-224.5M	$452.4M
PE Ratio